IP Library Granted Patent US 8,703,945
Granted Patent B2
US 8,703,945 · App. 10/594,380 · Granted Apr 22, 2014

Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin

Inventors: David J. Moody (Fife, GB); Jonathan W. Wiffen (Craigavon, GB)
Assignee: Redx Pharma Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,703,945
App. No.
10/594,380
Granted
Apr 22, 2014
Kind
B2
Abstract

There is provided a process for the preparation of a compound of formula (7) wherein R 1 represents an alkyl group; R 2 represents an aryl group; R 3 represents hydrogen, a protecting group or an alkyl group; and R 4 represents hydrogen, a protecting group or a SO 2 R 5 group where R 5 is an alkyl group, which comprises a) hydroxylating a compound of formula (1) wherein Y represents a halo group; P 1 represents hydrogen or a protecting group, and W represents ═O or —OP 2 , in which P 2 represents hydrogen or a protecting group, to give a compound of formula (2), b) oxidixing the compound of formula (2) to give a compound of formula (3), c) coupling the compound of formula (3) with a compound of formula (4), wherein R 3 represents a protecting group or an alkyl group; R 4 represents a protecting group or a SO 2 R 5 group where R 5 is an alkyl group; and R 6 represents (PR 7 R 8 )+X − or P(═O)R 7 R 8 in which X is an anion and R 7 and R 8 each independently is an alkyl, aryl.

Claims (26)

1. A process for the preparation of a compound of formula (7):

wherein

R 1 represents an isopropyl group;

R 2 represents a 4-fluorophenyl group;

R 3 represents a methyl group; and

R 4 represents a SO 2 R 5 group where R 5 is a methyl group, comprising the steps of:

a) hydroxylating a compound of formula (1):

wherein Y represents a halo group; P 1 represents hydrogen or a protecting group selected from the group consisting of benzyl, benzoyl, methyl, silyl, and tetrahydropyranyl; and W represents —OP 2 , in which P 2 represents a protecting group selected from the group consisting of benzyl, benzoyl, methyl, silyl, and tetrahydropyranyl, to give a compound of formula (2):

b) oxidising the compound of formula (2) to give a compound of formula (3):

c) coupling the compound of formula (3) with a compound of formula (4):

wherein R 1 represents an isopropyl group; R 2 represents a 4-fluorophenyl group; R 3 represents a methyl group; R 4 represents SO 2 R 5 group where R 5 is a methyl group; and R 6 represents P(═O)R 7 R 8 in which R 7 and R 8 each independently is a C 1-6 alkyl, C 6-12 aryl, C 1-6 alkoxy, or C 6-12 aryloxy group, to give a compound of formula (5):

wherein R 3 represents a methyl group; and R 4 represents a SO 2 R 5 group where R 5 is methyl group;

d) removing the P 2 protecting group and oxidising the compound of formula (5) to give a compound of formula (6):

and

e) subjecting the compound of formula (6) to ring-opening and removing any P 1 protecting group, to give a compound of formula (7).

2. The process of claim 1 , wherein Y represents independently for each occurrence Cl or Br.

3. The process of claim 1 , wherein P 1 represents benzyl, benzoyl, methyl, or silyl.

4. The process of claim 1 , wherein P 1 represents benzyl or benzoyl.

5. The process of claim 1 , wherein P 1 represents a trialkylsilyl or a triarylsilyl.

6. The process of claim 1 , wherein P 1 represents a silyl selected from the group consisting of trimethylsilyl, tert-butyldimethylsilyl, and tert-butyldiphenylsilyl.

7. The process of claim 1 , wherein P 2 represents benzyl.

8. The process of claim 1 , wherein P 2 represents methyl.

9. The process of claim 1 , wherein R 7 and R 8 are each independently a C 6-12 aryloxy group.

10. The process of claim 1 , wherein R 7 and R 8 each independently is methyl, ethyl, phenyl, tolyl, naphthyl, methoxy, ethoxy or phenoxy.

11. The process of claim 1 , wherein R 7 and R 8 represent phenoxy.

12. The process of claim 1 , wherein P 1 represents benzyl or benzoyl; and R 7 and R 8 represent phenoxy.

Assignments (7)
CHANGE OF NAME Recorded Apr 17, 2015
From: REDX PHARMA LIMITED
To: REDX PHARMA PLC
Reel/Frame 035455/0507 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2011
From: BRADFORD PHARMA LIMITED
To: REDX PHARMA LIMITED
Reel/Frame 027221/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2010
From: PIRAMAL HEALTHCARE UK LIMITED
To: BRADFORD PHARMA LIMITED
Reel/Frame 024021/0412 →
CHANGE OF NAME Recorded Mar 3, 2010
From: NPIL PHARMACEUTICALS (UK) LIMITED
To: PIRAMAL HEALTHCARE UK LIMITED
Reel/Frame 024021/0384 →
CORRECTIVE ASSIGNMENT TO CORRECT THE EXECUTION DATE OF INVENTOR JONATHAN W. WIFFEN FROM 11 FEBRUARY 2007 TO 11 JANUARY 2007 PREVIOUSLY RECORDED ON REEL 022039 FRAME 0618. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF THE INVENTION FROM INVENTORS DAVID J. MOODY AND JONATHAN W. WIFFEN TO AVECIA PHARMACEUTICALS LIMITED. Recorded Jan 8, 2009
From: MOODY, DAVID J.; WIFFEN, JONATHAN W.
To: AVECIA PHARMACEUTICALS LIMITED
Reel/Frame 022077/0220 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2008
From: MOODY, DAVID J.; WIFFEN, JONATHAN W.
To: AVECIA PHARMACEUTICALS LIMITED
Reel/Frame 022039/0500 →
CHANGE OF NAME Recorded Dec 30, 2008
From: AVECIA PHARMACEUTICALS LIMITED
To: NPIL PHARMACEUTICALS (UK) LIMITED
Reel/Frame 022039/0618 →
Priority Claims (1)
GB 0406757.5 · Mar 26, 2004 · national
Continuity (1)
Related Publication 20080281101A1 · Nov 13, 2008